Improving Diagnosis of Legume Allergy in Children
Launched by CENTRAL HOSPITAL, NANCY, FRANCE · May 21, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the LACID study, is focused on improving the way we diagnose legume allergies in children. Legumes, which include peanuts, soy, lentils, peas, lupin, chickpeas, beans, and fenugreek, can cause serious allergic reactions, but only a few of these foods are required to be clearly labeled on packaging in Europe. This makes it challenging for families to identify hidden allergens in processed foods, especially as more schools are serving vegetarian meals that often contain legumes. The study aims to find and analyze the proteins in lupin, fenugreek, and peas that might cause allergies, with the goal of developing better allergy tests.
To participate in the trial, children must be sensitized to lupin, fenugreek, or pea, which means their bodies have shown a reaction to these foods, even if they haven't had a real allergic reaction. However, children currently undergoing certain treatments are not eligible. Participants will undergo tests that may help identify which legumes they truly need to avoid, making everyday life easier and less stressful for families. This research could lead to quicker and more accurate diagnoses, allowing children to enjoy more foods safely.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Sensitised to lupine, fenugreek or pea
- Exclusion Criteria:
- • on going anti-IgE treatment or in the last 6 months
About Central Hospital, Nancy, France
Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Amandine Divaret-Chauveau, MD, PhD
Principal Investigator
Pediatric Allergy Unit, University Hospital of Nancy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported